Trial intelligence / Profile preview

Duration of amiodarone therapy for new atrial fibrillation after cardiac surgery

2004-002208-14Phase 4Terminated

Sponsor
Cardiff and Vale University Health Board
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Cardiff and Vale University Health Board. Primary endpoints: Optimal duration of amiodarone therapy and Safety and side effect profile. Started Jun 2005; status: terminated.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on 2004-002208-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002208-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call